Gene · 3804
Papers2,392
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,392
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Predicting skin melanoma progression via LAG-3, TIGIT and HAVCR2. | Funct Integr Genomics | 2026 | 41746432 | PubTator, text mining | PubMed |
| Determinants of Efficacy and Optimization of Chimeric Antigen Receptor T-Cell Therapy for Treating Multiple Myeloma: Current Status and Future Perspectives. | Cells | 2026 | 41744823 | PubTator, text mining | PubMed |
| Inhibitory NK receptor expression associates with altered antimalarial function of γδ T cells. | PLoS Pathog | 2026 | 41632809 | PubTator, text mining | PubMed |
| Targeting cancer stem cells as the most aggressive and tumor-initiating cells. | Transl Oncol | 2026 | 41604836 | PubTator, text mining | PubMed |
| Fifty Years of Natural Killer Cells: Milestones and Future Horizons. | Scand J Immunol | 2026 | 41580304 | PubTator, text mining | PubMed |
| Resident CD49a+CD103+NKG2C+ NK cells restrict HIV infection in human lymphoid tissue explants. | Sci Adv | 2026 | 41576166 | PubTator, text mining | PubMed |
| Adalimumab-Induced Changes in NK Cells Phenotype, Receptors, and Functions After Clinical Remission of Behçet's Uveitis. | Am J Ophthalmol | 2026 | 41564966 | PubTator, text mining | PubMed |
| Proteome-Wide Mendelian Randomization Implicates Shared Necroptosis-Ferroptosis Effectors in Causal Pathways of Multiple Sclerosis Susceptibility. | Ann N Y Acad Sci | 2026 | 41387240 | PubTator, text mining | PubMed |
| Single-cell immune transcriptomics reveals an inflammatory-inhibitory set-point spectrum in autoimmune diabetes. | JCI Insight | 2026 | 41325163 | PubTator, text mining | PubMed |
| The predictive, preventive, and personalized medicine of multiple sclerosis: ferroptosis and circulating proteins. | Neurol Res | 2026 | 40813130 | PubTator, text mining | PubMed |
| Preliminary Study on GZMA- and GSDMB-Associated Pyroptosis and CD8+ T Cell-Mediated Immune Evasion in Skin Cutaneous Melanoma. | Curr Top Med Chem | 2026 | 40755114 | PubTator, text mining | PubMed |
| Integrating killer cell immunoglobulin-like receptor highresolution genotyping for predicting transplant outcomes in allogeneic hematopoietic stem cell transplantation. | Haematologica | 2026 | 40637775 | PubTator, text mining | PubMed |
| KIR AA individuals possess strong inhibitory KIR alleles alongside HLA ligands that are protective against leukemia in the Chinese population. | Front Genet | 2025 | 41717357 | PubTator, text mining | PubMed |
| MicroRNA-mediated regulation of natural killer cells development, effector functions, and antitumor responses. | Cancer Cell Int | 2025 | 41331607 | PubTator, text mining | PubMed |
| Site-specific genome engineering of primary human natural killer cells for programmable anti-tumor function. | bioRxiv | 2025 | 41279666 | PubTator, text mining | PubMed |
| Targeting orthotopic and metastatic pancreatic cancer with allogeneic stem cell-engineered mesothelin-redirected CAR-NKT cells. | Proc Natl Acad Sci U S A | 2025 | 41269799 | PubTator, text mining | PubMed |
| Coralysis enables sensitive identification of imbalanced cell types and states in single-cell data via multi-level integration. | Nucleic Acids Res | 2025 | 41242525 | PubTator, text mining | PubMed |
| Crosstalk between decidual natural killer cells and extravillous trophoblasts at the maternal-fetal interface: current status and future perspectives. | Front Immunol | 2025 | 41200190 | PubTator, text mining | PubMed |
| The advantages of NK cell vaccines in solid carcinoma clinical trials: conducted by various biology strategy and technology. | Front Med (Lausanne) | 2025 | 41179878 | PubTator, text mining | PubMed |
| Targeting triple-negative breast cancer using cord-blood CD34⁺ HSPC-derived mesothelin-specific CAR-NKT cells with potent antitumor activity. | J Hematol Oncol | 2025 | 41077583 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3804/papers?page=2